Neurenati Therapeutics

Website
Current Valuation
$6.4M
As of September 25, 2025
Total Funding Raised
$4.3M
Last Round
Seed Round

$2.2M

Last Funding
Sep 2025

Funding date

Capital Efficiency
1.48x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Neurenati Therapeutics is currently valued at $6.4M as of September 25, 2025. The company has raised a total of $4.3M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.48x, Neurenati Therapeutics has achieved a valuation that is 1.48 times the total capital raised.

Track Neurenati Therapeutics Valuation Updates

Get notified when Neurenati Therapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for Neurenati Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Neurenati Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Neurenati Therapeutics Worth in 2026?

Neurenati Therapeutics is a leading private company in the technology sector. Track Neurenati Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Neurenati Therapeutics Valuation is Determined

Private company valuations like Neurenati Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.